tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Risinger, 117 are a BUY (60.94%), 63 are a HOLD (32.81%), 12 are a SELL (6.25%).
Analyst David Risinger, currently employed at LEERINK, carries an average stock price target met ratio of 73.31% that have a potential upside of 17.92% achieved within 218 days.
David Risinger’s has documented 417 price targets and ratings displayed on 31 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on REGN, Regeneron Pharmaceuticals at 24-Sep-2024.
Analyst best performing recommendations are on BHC (BAUSCH HEALTH COMPANIES).
The best stock recommendation documented was for ALKS (ALKERMES PLC) at 1/21/2016. The price target of $35 was fulfilled within 1 day with a profit of $1.31 (3.89%) receiving and performance score of 38.88.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$226
$22.45 (11.03%)
$195
5 days ago
(31-Oct-2024)
8/9 (88.89%)
$22.13 (10.85%)
293
Buy
$231
$27.45 (13.49%)
$218
5 days ago
(31-Oct-2024)
12/14 (85.71%)
$27.13 (13.31%)
488
Buy
$215
$11.45 (5.63%)
$170
11 days ago
(25-Oct-2024)
9/10 (90%)
$27.15 (14.45%)
484
Buy
$212
$8.45 (4.15%)
$200
29 days ago
(07-Oct-2024)
14/15 (93.33%)
$17.88 (9.21%)
175
Buy
$225
$21.45 (10.54%)
$180
29 days ago
(07-Oct-2024)
14/15 (93.33%)
$30.88 (15.91%)
715
Which stock is David Risinger is most bullish on?
Which stock is David Risinger is most reserved on?
What Year was the first public recommendation made by David Risinger?
